{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:44:39Z","timestamp":1793105079218,"version":"4.5.0"},"reference-count":160,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with curative surgical interventions feasible for a minority of patients. This review highlights recent advances in thermal (e.g., radiofrequency ablation, microwave ablation, and cryoablation) and nonthermal (e.g., ethanol ablation and irreversible electroporation) ablative modalities as curative-intent alternatives to surgery. Evolving applications of transcatheter intra-arterial radioembolization (TARE) with ablative dosimetry will be explored, and histotripsy, an emerging technology, will be introduced.<\/jats:p>","DOI":"10.3390\/cancers17193251","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:46:56Z","timestamp":1759841216000},"page":"3251","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent Advances in Ablative Therapies for Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"17","author":[{"given":"Saad","family":"Abu Zahra","sequence":"first","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6724-2042","authenticated-orcid":false,"given":"Arsalan","family":"Nadeem","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Kundu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Haggaz","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent T.","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-788X","authenticated-orcid":false,"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0092-249X","authenticated-orcid":false,"given":"Andrew C.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular Carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e240333","DOI":"10.1148\/radiol.240333","article-title":"The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy","volume":"316","author":"Lewandowski","year":"2025","journal-title":"Radiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation Segmentectomy for Curative Intent of Unresectable Very Early to Early Stage Hepatocellular Carcinoma (RASER): A Single-Centre, Single-Arm Study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s00330-005-2652-x","article-title":"Radiofrequency Thermal Ablation of Liver Tumors","volume":"15","author":"Buscarini","year":"2005","journal-title":"Eur. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00270-009-9736-y","article-title":"Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours","volume":"33","author":"Crocetti","year":"2010","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104685","DOI":"10.4061\/2011\/104685","article-title":"Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review","volume":"2011","author":"Minami","year":"2011","journal-title":"Int. J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3348\/kjr.2000.1.4.175","article-title":"Radiofrequency Thermal Ablation of Hepatocellular Carcinomas","volume":"1","author":"Lim","year":"2000","journal-title":"Korean J. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jvir.2019.04.023","article-title":"Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin","volume":"30","author":"Celik","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/02656736.2020.1823022","article-title":"How Large Is the Periablational Zone after Radiofrequency and Microwave Ablation? Computer-Based Comparative Study of Two Currently Used Clinical Devices","volume":"37","author":"Trujillo","year":"2020","journal-title":"Int. J. Hyperth."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3348\/kjr.2021.0451","article-title":"Ablative Outcomes of Various Energy Modes for No-Touch and Peripheral Tumor-Puncturing Radiofrequency Ablation: An Ex Vivo Simulation Study","volume":"23","author":"Cha","year":"2022","journal-title":"Korean J. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1148\/radiol.2021200153","article-title":"The 10-Year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 Cm or Smaller: Primary versus Recurrent HCC","volume":"300","author":"Bai","year":"2021","journal-title":"Radiology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/SLA.0000000000001384","article-title":"Complete Pathologic Response to Pretransplant Locoregional Therapy for Hepatocellular Carcinoma Defines Cancer Cure after Liver Transplantation: Analysis of 501 Consecutively Treated Patients","volume":"262","author":"Agopian","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2214\/AJR.22.28385","article-title":"Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database","volume":"220","author":"Sarwar","year":"2023","journal-title":"Am. J. Roentgenol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/lt.25381","article-title":"Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pretransplant Radiology","volume":"25","author":"Serra","year":"2019","journal-title":"Liver Transpl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria","volume":"252","author":"Huang","year":"2010","journal-title":"Ann. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1200\/JCO-24-02030","article-title":"Surgery Versus Ablation for Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF-RCT Trial) and a Nonrandomized Prospective Observational Trial (SURF-Cohort Trial)","volume":"43","author":"Kawaguchi","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1440-1673.2007.01871.x","article-title":"Post-radiofrequency Ablation Syndrome after Percutaneous Radiofrequency of Abdominal Tumours: One Centre Experience and Review of Published Works","volume":"51","author":"Carrafiello","year":"2007","journal-title":"Australas. Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hwang, S., Kim, J.H., Yu, S.J., and Lee, J.M. (2024). Incremental High Power Radiofrequency Ablation with Multi-Electrodes for Small Hepatocellular Carcinoma: A Prospective Study. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03358-w"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kato, K., Abe, H., Ika, M., Sakamoto, Y., Takeuchi, M., Komazaki, S., Takeda, S., Ito, S., Shimizu, S., and Matsuo, R. (2025). Efficacy of Fusion Imaging and Cone-Beam Computed Tomography Guided Radiofrequency Ablation for Hepatocellular Carcinoma Poorly Visualized on Ultrasonography. Oncology, ahead of print.","DOI":"10.1159\/000546427"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20311","DOI":"10.1002\/cam4.6602","article-title":"Radiofrequency Ablation Combined with Toripalimab for Recurrent Hepatocellular Carcinoma: A Prospective Controlled Trial","volume":"12","author":"Wen","year":"2023","journal-title":"Cancer Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1080\/02656736.2021.1991011","article-title":"Combination Therapy with PD-1 Blockade and Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma: A Propensity Score Matching Analysis","volume":"38","author":"Wang","year":"2021","journal-title":"Int. J. Hyperth."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.5009\/gnl.2010.4.S1.S113","article-title":"Radiofrequency Ablation of Hepatocellular Carcinoma: Pros and Cons","volume":"4","author":"Rhim","year":"2010","journal-title":"Gut Liver"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e29321","DOI":"10.1097\/MD.0000000000029321","article-title":"Efficacy and Safety of Microwave Ablation and Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"101","author":"Dou","year":"2022","journal-title":"Medicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5152\/tjg.2019.17191","article-title":"Percutaneous Microwave Ablation for HCV-Related Hepatocellular Carcinoma: Efficacy, Safety, and Survival","volume":"30","author":"Darweesh","year":"2019","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1007\/s00261-021-03008-9","article-title":"Efficacy of Microwave Ablation versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Propensity Score Analysis","volume":"46","author":"Suwa","year":"2021","journal-title":"Abdom. Radiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/02656736.2020.1790678","article-title":"Percutaneous Radiofrequency Ablation of HCC: Reduced Ablation Duration and Increased Ablation Size Using Single, Internally Cooled Electrodes with an Optimized Pulsing Algorithm","volume":"37","author":"Solbiati","year":"2020","journal-title":"Int. J. Hyperth."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2468-1253(18)30029-3","article-title":"Efficacy of Microwave Ablation versus Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Chronic Liver Disease: A Randomised Controlled Phase 2 Trial","volume":"3","author":"Duran","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-020-02734-1","article-title":"Microwave Ablation Enhances Tumor-Specific Immune Response in Patients with Hepatocellular Carcinoma","volume":"70","author":"Leuchte","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Habibollahi, P., Sheth, R.A., and Cressman, E.N.K. (2020). Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review. Cancers, 13.","DOI":"10.3390\/cancers13010104"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1007\/s00330-017-4740-0","article-title":"Microwave Ablation for the Treatment of Hepatocellular Carcinoma That Met Up-to-Seven Criteria: Feasibility, Local Efficacy and Long-Term Outcomes","volume":"27","author":"Xu","year":"2017","journal-title":"Eur. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.4254\/wjh.v7.i25.2578","article-title":"Microwave Ablation of Hepatocellular Carcinoma","volume":"7","author":"Poggi","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00270-018-2089-7","article-title":"Adjunctive Thermoprotection During Percutaneous Thermal Ablation Procedures: Review of Current Techniques","volume":"42","author":"Garnon","year":"2019","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jvir.2013.04.014","article-title":"No-Touch Wedge Ablation Technique of Microwave Ablation for the Treatment of Subcapsular Tumors in the Liver","volume":"24","author":"Patel","year":"2013","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/hepr.14221","article-title":"Microwave Thermosphere Ablation Versus Radiofrequency Ablation in Hepatocellular Carcinoma: Optimizing Treatment Strategies for Tumor Size and Malignancy Grade","volume":"55","author":"Tamai","year":"2025","journal-title":"Hepatol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e01082","DOI":"10.14309\/crj.0000000000001082","article-title":"Gastric Perforation After Microwave Ablation to Adjacent Hepatocellular Lesion","volume":"10","author":"Sharif","year":"2023","journal-title":"ACG Case Rep. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e937832","DOI":"10.12659\/MSM.937832","article-title":"Application of Indocyanine Green Fluorescence Imaging Combined with Laparoscopic Ultrasound in Laparoscopic Microwave Ablation of Liver Cancer","volume":"28","author":"Hu","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.2016152508","article-title":"Effects of Microwave Ablation on Arterial and Venous Vasculature after Treatment of Hepatocellular Carcinoma","volume":"281","author":"Chiang","year":"2016","journal-title":"Radiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1590\/S1677-55382011000600002","article-title":"Biophysiologic Considerations in Cryoablation: A Practical Mechanistic Molecular Review","volume":"37","author":"Maccini","year":"2011","journal-title":"Int. Braz. J. Urol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1089\/end.2009.0587","article-title":"The Effect of Argon Gas Pressure on Ice Ball Size and Rate of Formation","volume":"24","author":"Sprenkle","year":"2010","journal-title":"J. Endourol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12957-017-1196-2","article-title":"Effects of Radiofrequency Ablation versus Other Ablating Techniques on Hepatocellular Carcinomas: A Systematic Review and Meta-Analysis","volume":"15","author":"Luo","year":"2017","journal-title":"World J. Surg. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2214\/AJR.16.17582","article-title":"Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes","volume":"209","author":"Glazer","year":"2017","journal-title":"Am. J. Roentgenol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yacr.2019.04.007","article-title":"Advances in the Ablative Management of Hepatocellular Carcinoma","volume":"1","author":"Toskich","year":"2019","journal-title":"Adv. Clin. Radiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s00330-018-5617-6","article-title":"Percutaneous Cryoablation for Perivascular Hepatocellular Carcinoma: Therapeutic Efficacy and Vascular Complications","volume":"29","author":"Kim","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e931473","DOI":"10.12659\/MSM.931473","article-title":"Percutaneous Argon-Helium Cryoablation for Small Hepatocellular Carcinoma Located Adjacent to a Major Organ or Viscus: A Retrospective Study of 92 Patients at a Single Center","volume":"27","author":"Zhang","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/hep.27548","article-title":"Multicenter Randomized Controlled Trial of Percutaneous Cryoablation versus Radiofrequency Ablation in Hepatocellular Carcinoma","volume":"61","author":"Wang","year":"2015","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1245\/s10434-014-4114-7","article-title":"Cryoablation Provides Superior Local Control of Primary Hepatocellular Carcinomas of >2 Cm Compared with Radiofrequency Ablation and Microwave Coagulation Therapy: An Underestimated Tool in the Toolbox","volume":"22","author":"Ei","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.asjsur.2024.10.233","article-title":"Cryoablation versus Microwave Ablation in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"48","author":"Tang","year":"2025","journal-title":"Asian J. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MCG.0000000000000201","article-title":"Advances in Clinical Application of Cryoablation Therapy for Hepatocellular Carcinoma and Metastatic Liver Tumor","volume":"48","author":"Hu","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2017.10.004","article-title":"Percutaneous Treatment of Hepatocellular Carcinoma: State of the Art and Innovations","volume":"68","author":"Nault","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/liv.15817","article-title":"Potent Induction of Antitumor Immunity by Combining Cryo-thermal Ablation with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma","volume":"44","author":"Qian","year":"2024","journal-title":"Liver Int."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Liu, Q., Zhang, C., Chen, X., and Han, Z. (2024). Modern Cancer Therapy: Cryoablation Meets Immune Checkpoint Blockade. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1323070"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2373319","DOI":"10.1080\/02656736.2024.2373319","article-title":"Cryoablation Combined with Dual Immune Checkpoint Blockade Enhances Antitumor Efficacy in Hepatocellular Carcinoma Model Mice","volume":"41","author":"Gu","year":"2024","journal-title":"Int. J. Hyperth."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.jvir.2023.05.008","article-title":"Stimulating Antitumoral Immunity by Percutaneous Cryoablation and Combination Immunoadjuvant Therapy in a Murine Model of Hepatocellular Carcinoma","volume":"34","author":"Mandt","year":"2023","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rong, G., Bai, W., Dong, Z., Wang, C., Lu, Y., Zeng, Z., Qu, J., Lou, M., Wang, H., and Gao, X. (2015). Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123065"},{"key":"ref_61","first-page":"e2126992","article-title":"Long-Term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma","volume":"4","author":"Zhang","year":"2021","journal-title":"J. Am. Med. Assoc. Netw. Open"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/02656736.2022.2048095","article-title":"Combined Radiofrequency Ablation or Microwave Ablation with Transarterial Chemoembolization Can Increase Efficiency in Intermediate-Stage Hepatocellular Carcinoma without More Complication: A Systematic Review and Meta-Analysis","volume":"39","author":"Yang","year":"2022","journal-title":"Int. J. Hyperth."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12957-022-02643-w","article-title":"Single Medium-Sized Hepatocellular Carcinoma Treated with Sequential Conventional Transarterial Chemoembolization (cTACE) and Microwave Ablation at 4 Weeks versus cTACE Alone: A Propensity Score","volume":"20","author":"Zhu","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00261-021-03368-2","article-title":"Comparison of Combined Transarterial Chemoembolization and Ablations in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"47","author":"Keshavarz","year":"2022","journal-title":"Abdom. Radiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/02656736.2018.1493235","article-title":"Large Hepatocellular Carcinomas: Treatment with Transarterial Chemoembolization Alone or in Combination with Percutaneous Cryoablation","volume":"35","author":"Cui","year":"2018","journal-title":"Int. J. Hyperth."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.18632\/oncotarget.24029","article-title":"Cryoablation with Drug-Loaded Bead Embolization in the Treatment of Unresectable Hepatocellular Carcinoma: Safety and Efficacy Analysis","volume":"9","author":"Zeng","year":"2018","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jvir.2011.09.020","article-title":"Electron Microscopic Demonstration and Evaluation of Irreversible Electroporation-Induced Nanopores on Hepatocyte Membranes","volume":"23","author":"Lee","year":"2012","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e1571","DOI":"10.7717\/peerj.1571","article-title":"Rat Liver Regeneration Following Ablation with Irreversible Electroporation","volume":"4","author":"Golberg","year":"2016","journal-title":"PeerJ"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JHC.S129063","article-title":"Irreversible Electroporation of Hepatocellular Carcinoma: Patient Selection and Perspectives","volume":"4","author":"Zimmerman","year":"2017","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.diii.2023.08.003","article-title":"Robotic-Assisted Percutaneous Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma","volume":"104","author":"Dumortier","year":"2023","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_71","first-page":"151","article-title":"Effectiveness and Safety of Irreversible Electroporation for Recurrent Hepatocellular Carcinoma Ineligible for Thermal Ablation after Surgery","volume":"3","author":"Wang","year":"2020","journal-title":"J. Interv. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"190","DOI":"10.14218\/JCTH.2021.00019","article-title":"Irreversible Electroporation for Hepatocellular Carcinoma Abutting the Diaphragm: A Prospective Single-Center Study","volume":"10","author":"Ma","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00270-020-02666-4","article-title":"Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre","volume":"44","author":"Freeman","year":"2021","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/00365521.2021.1930145","article-title":"Irreversible Electroporation versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Single Centre Propensity-Matched Comparison","volume":"56","author":"Freeman","year":"2021","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1148\/radiol.2017161413","article-title":"Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series","volume":"284","author":"Sutter","year":"2017","journal-title":"Radiology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Niessen, C., Thumann, S., Beyer, L., Pregler, B., Kramer, J., Lang, S., Teufel, A., Jung, E.M., Stroszczynski, C., and Wiggermann, P. (2017). Percutaneous Irreversible Electroporation: Long-Term Survival Analysis of 71 Patients with Inoperable Malignant Hepatic Tumors. Sci. Rep., 7.","DOI":"10.1038\/srep43687"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jvir.2015.10.002","article-title":"Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values","volume":"27","author":"Dollinger","year":"2016","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.hpb.2016.03.609","article-title":"Evaluation of Tolerability and Efficacy of Irreversible Electroporation (IRE) in Treatment of Child-Pugh B (7\/8) Hepatocellular Carcinoma (HCC)","volume":"18","author":"Bhutiani","year":"2016","journal-title":"HPB"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1007\/s00330-021-07742-y","article-title":"Efficacy and Safety of Irreversible Electroporation for Malignant Liver Tumors: A Systematic Review and Meta-Analysis","volume":"31","author":"Gupta","year":"2021","journal-title":"Eur. Radiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria\u2014A 10-Year Update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107046","DOI":"10.1016\/j.ejso.2023.107046","article-title":"Irreversible Electroporation of Hepatocellular Carcinoma and Colorectal Cancer Liver Metastases: A Nationwide Multicenter Study with Short- and Long-Term Follow-Up","volume":"49","author":"Holmquist","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12957-024-03614-z","article-title":"A Multicenter, Randomized, Parallel-Controlled Clinical Trial Protocol to Evaluate the Safety and Efficacy of Irreversible Electroporation Compared with Radiofrequency Ablation for the Treatment of Small Hepatocellular Carcinoma","volume":"22","author":"Cheng","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v7.i4.673","article-title":"Recent Advances in Multidisciplinary Management of Hepatocellular Carcinoma","volume":"7","author":"Gomaa","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/000313481908500141","article-title":"Irreversible Electroporation as a Bridge to Liver Transplantation","volume":"85","author":"Cannon","year":"2019","journal-title":"Am. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s11912-023-01452-y","article-title":"New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors","volume":"25","author":"Yun","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Arena, C.B., Sano, M.B., Rossmeisl, J.H., Caldwell, J.L., Garcia, P.A., Rylander, M.N., and Davalos, R.V. (2011). High-Frequency Irreversible Electroporation (H-FIRE) for Non-Thermal Ablation without Muscle Contraction. BioMed Eng. Online, 10.","DOI":"10.1186\/1475-925X-10-102"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jvir.2020.09.015","article-title":"Ureteric Injury after Image-Guided Ablation of Renal Cell Cancer with Irreversible Electroporation","volume":"32","author":"Ng","year":"2021","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_88","first-page":"693","article-title":"Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial","volume":"157","author":"Wang","year":"2022","journal-title":"J. Am. Med. Assoc. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11548-016-1485-1","article-title":"Evaluation of a Robotic System for Irreversible Electroporation (IRE) of Malignant Liver Tumors: Initial Results","volume":"12","author":"Beyer","year":"2017","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00270-022-03267-z","article-title":"Evaluation of a New CT-Guided Robotic System for Percutaneous Needle Insertion for Thermal Ablation of Liver Tumors: A Prospective Pilot Study","volume":"45","author":"Roux","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/2013.jamasurg.100","article-title":"Irreversible Electroporation for the Ablation of Liver Tumors: Are We There Yet?","volume":"147","author":"Charpentier","year":"2012","journal-title":"Arch. Surg."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00432-010-0909-5","article-title":"Pathobiological Features of Small Hepatocellular Carcinoma: Correlation between Tumor Size and Biological Behavior","volume":"137","author":"Lu","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/1097-0142(19911001)68:7<1524::AID-CNCR2820680711>3.0.CO;2-O","article-title":"Percutaneous Ethanol Injection Therapy for Hepatocellular Carcinoma. A Histopathologic Study","volume":"68","author":"Shiina","year":"1991","journal-title":"Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2004.09.003","article-title":"Radiofrequency Ablation Improves Prognosis Compared with Ethanol Injection for Hepatocellular Carcinoma \u22644 Cm","volume":"127","author":"Lin","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00270-004-4082-6","article-title":"Treatment of Neuroendocrine Cancer Metastatic to the Liver: The Role of Ablative Techniques","volume":"28","author":"Atwell","year":"2005","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiol.2281020718","article-title":"Small Hepatocellular Carcinoma in Cirrhosis: Randomized Comparison of Radio-Frequency Thermal Ablation versus Percutaneous Ethanol Injection","volume":"228","author":"Lencioni","year":"2003","journal-title":"Radiology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3109\/00365529709002998","article-title":"Percutaneous Ethanol Injection in the Treatment of Hepatocellular Carcinoma: A Multicenter Survey of Evaluation Practices and Complication Rates","volume":"32","author":"Stasi","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-9966-27-28","article-title":"Pancreatitis after Percutaneous Ethanol Injection into HCC: A Minireview of the Literature","volume":"27","author":"Zardi","year":"2008","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.ijrobp.2006.02.061","article-title":"Yttrium-90 Microspheres for the Treatment of Hepatocellular Carcinoma: A Review","volume":"66","author":"Salem","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies","volume":"17","author":"Salem","year":"2006","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13139-021-00709-3","article-title":"Transarterial Radioembolization Agents: A Review of the Radionuclide Agents and the Carriers","volume":"55","author":"Alrfooh","year":"2021","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_102","unstructured":"FDA (2021). TheraSphere Y-90 Glass Microspheres for Unresectable Hepatocellular Carcinoma, FDA."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus Standard Dosimetry Approach of Selective Internal Radiation Therapy in Patients with Locally Advanced Hepatocellular Carcinoma (DOSISPHERE-01): A Randomised, Multicentre, Open-Label Phase 2 Trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 Radioembolization for Intermediate-Advanced Hepatocellular Carcinoma: A Phase 2 Study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/cncr.29275","article-title":"Open-label Prospective Study of the Safety and Efficacy of Glass-based Yttrium 90 Radioembolization for Infiltrative Hepatocellular Carcinoma with Portal Vein Thrombosis","volume":"121","author":"Kokabi","year":"2015","journal-title":"Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00270-011-0292-x","article-title":"Treating and Downstaging Hepatocellular Carcinoma in the Caudate Lobe with Yttrium-90 Radioembolization","volume":"35","author":"Ibrahim","year":"2012","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jhep.2025.01.005","article-title":"Radiation Segmentectomy for Early Hepatocellular Carcinoma Is Curative","volume":"82","author":"Salem","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-Absorbed Radiation Dose to Pathological Necrosis in Hepatocellular Carcinoma: Confirmatory Multicenter Analysis in 45 Explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Sarwar, A., Nasser, I., Weinstein, J.L., Odeh, M., Babar, H., Dinh, D., Curry, M., Bullock, A., Eckhoff, D., and Dib, M. (2025). Histopathologic Outcomes of Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Yttrium-90 Resin Microspheres. Eur. J. Nucl. Med. Mol. Imaging, ahead of print.","DOI":"10.1007\/s00259-025-07471-0"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jvir.2025.05.009","article-title":"Histopathologic Response and Oncologic Outcomes after Segmental and Subsegmental Transarterial Chemoembolization and Radioembolization for Hepatocellular Carcinoma","volume":"36","author":"Sher","year":"2025","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1148\/radiol.2016160718","article-title":"Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 Cm: A Propensity Score Matching Study","volume":"283","author":"Biederman","year":"2017","journal-title":"Radiology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2967\/jnumed.121.263147","article-title":"Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection","volume":"63","author":"Kim","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jvir.2022.03.021","article-title":"Radiation Segmentectomy for the Treatment of Solitary Hepatocellular Carcinoma: Outcomes Compared with Those of Surgical Resection","volume":"33","author":"Montazeri","year":"2022","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jvir.2017.02.018","article-title":"Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score\u2013Matched Study","volume":"28","author":"Padia","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable Solitary Hepatocellular Carcinoma Not Amenable to Radiofrequency Ablation: Multicenter Radiology-Pathology Correlation and Survival of Radiation Segmentectomy: VOUCHE ET AL","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"key":"ref_119","first-page":"290","article-title":"Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-Year Outcomes","volume":"24","author":"Gordon","year":"2025","journal-title":"Clin. Color. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e6745","DOI":"10.1097\/MD.0000000000006745","article-title":"Barcelona Clinic Liver Cancer-Stage C Hepatocellular Carcinoma: A Novel Approach to Subclassification and Treatment","volume":"96","author":"Jun","year":"2017","journal-title":"Medicine"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2214\/AJR.20.23478","article-title":"Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma","volume":"216","author":"Lokken","year":"2021","journal-title":"Am. J. Roentgenol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1080\/00365521.2017.1370008","article-title":"Retrograde Portal Vein Flow and Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma\u2014A Case\u2013Control Study","volume":"52","author":"Kirstein","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1007\/s00330-017-5145-9","article-title":"Portal Hypertension Is Associated with Poor Outcome of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma","volume":"28","author":"Choi","year":"2018","journal-title":"Eur. Radiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y Microspheres: Angiographic and Technical Considerations","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_125","first-page":"293","article-title":"Clinical Evaluation of the Partition Model for Estimating Radiation Doses from Yttrium-90 Microspheres in the Treatment of Hepatic Cancer","volume":"24","author":"Ho","year":"1997","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11864-020-0725-3","article-title":"Curative-Intent Therapies in Localized Hepatocellular Carcinoma","volume":"21","author":"Mahler","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prro.2023.08.016","article-title":"Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus","volume":"14","author":"Yanagihara","year":"2024","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ijrobp.2023.09.049","article-title":"Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 Cm) Hepatocellular Carcinoma: A Retrospective Analysis","volume":"118","author":"Hsieh","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/JHC.S507267","article-title":"Radiation Segmentectomy or Ablative External Beam Radiation Therapy as Initial Treatment for Solitary Hepatocellular Carcinoma: A Multicenter Experience","volume":"12","author":"Montazeri","year":"2025","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1109\/TUFFC.2014.6722611","article-title":"Histotripsy beyond the Intrinsic Cavitation Threshold Using Very Short Ultrasound Pulses: Microtripsy","volume":"61","author":"Lin","year":"2014","journal-title":"IEEE Trans. Ultrason. Ferroelect. Freq. Control"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.ultrasmedbio.2015.03.026","article-title":"Histotripsy Lesion Formation Using an Ultrasound Imaging Probe Enabled by a Low-Frequency Pump Transducer","volume":"41","author":"Lin","year":"2015","journal-title":"Ultrasound Med. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1109\/TUFFC.2014.6722617","article-title":"Dual-Beam Histotripsy: A Low-Frequency Pump Enabling a High-Frequency Probe for Precise Lesion Formation","volume":"61","author":"Lin","year":"2014","journal-title":"IEEE Trans. Ultrason. Ferroelect. Freq. Control"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.ultrasmedbio.2015.04.007","article-title":"Effects of Ultrasound Frequency on Nanodroplet-Mediated Histotripsy","volume":"41","author":"Vlaisavljevich","year":"2015","journal-title":"Ultrasound Med. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ultrasmedbio.2012.09.004","article-title":"Probability of Cavitation for Single Ultrasound Pulses Applied to Tissues and Tissue-Mimicking Materials","volume":"39","author":"Maxwell","year":"2013","journal-title":"Ultrasound Med. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"234103","DOI":"10.1063\/1.4836315","article-title":"Dual-Frequency Focused Ultrasound Using Optoacoustic and Piezoelectric Transmitters for Single-Pulsed Free-Field Cavitation in Water","volume":"103","author":"Baac","year":"2013","journal-title":"Appl. Phys. Lett."},{"key":"ref_136","unstructured":"HistoSonics, Inc. (2025). Multi-Center, Open-Labeled, Non-Randomized Study to Evaluate the Acute Technical Performance and Safety Profile of the VORTX Rx\u00ae for Ablation of Primary and Metastatic Liver Tumors (Theresa Study), HistoSonics, Inc."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/02656736.2022.2112309","article-title":"First-in-Man Histotripsy of Hepatic Tumors: The THERESA Trial, a Feasibility Study","volume":"39","author":"Serres","year":"2022","journal-title":"Int. J. Hyperth."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e233051","DOI":"10.1148\/radiol.233051","article-title":"The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors","volume":"312","author":"Wiggermann","year":"2024","journal-title":"Radiology"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Ziemlewicz, T.J., Critchfield, J.J., Mendiratta-Lala, M., Wiggermann, P., Pech, M., Serres-Cr\u00e9ixams, X., Lubner, M., Wah, T.M., Littler, P., and Davis, C.R. (2025). The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors: 1-Year Update of Clinical Outcomes. Ann. Surg., ahead of print.","DOI":"10.1097\/SLA.0000000000006720"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1478-3231.2012.02838.x","article-title":"Percutaneous Ethanol Injection for Hepatocellular Carcinoma: 20-year Outcome and Prognostic Factors","volume":"32","author":"Shiina","year":"2012","journal-title":"Liver Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/02656736.2021.1905189","article-title":"Histotripsy: The First Noninvasive, Non-Ionizing, Non-Thermal Ablation Technique Based on Ultrasound","volume":"38","author":"Xu","year":"2021","journal-title":"Int. J. Hyperth."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/atm-22-2578","article-title":"Research Progress and Clinical Evaluation of Histotripsy: A Narrative Review","volume":"11","author":"Li","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Uysal, M., Wehrle, C.J., Satish, S., Knott, E., Hong, H., Allkushi, E., Schlegel, A., Berber, E., Aucejo, F., and Kim, J. (2025). Histotripsy of Liver Tumors: Patient Selection, Ethical Discussions, and How We Do It. Cancers, 17.","DOI":"10.20944\/preprints202501.1472.v1"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/uog.8880","article-title":"Non-invasive Pulsed Cavitational Ultrasound for Fetal Tissue Ablation: Feasibility Study in a Fetal Sheep Model","volume":"37","author":"Kim","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"102000","DOI":"10.1016\/j.gassur.2025.102000","article-title":"The First International Experience with Histotripsy: A Safety Analysis of 230 Cases","volume":"29","author":"Wehrle","year":"2025","journal-title":"J. Gastrointest. Surg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jvir.2019.01.023","article-title":"Robotically-Assisted Sonic Therapy for Renal Ablation in a Live Porcine Model: Initial Preclinical Results","volume":"30","author":"Knott","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.urology.2012.06.020","article-title":"Histotripsy of Renal Implanted VX-2 Tumor in a Rabbit Model: Investigation of Metastases","volume":"80","author":"Styn","year":"2012","journal-title":"Urology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jvir.2025.06.002","article-title":"Hyperprogression and Systemic Metastasis of Cholangiocarcinoma after Histotripsy Therapy","volume":"36","author":"Berman","year":"2025","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1177\/02841851231187638","article-title":"Fusion Imaging versus Ultrasound-Guided Percutaneous Thermal Ablation of Liver Cancer: A Meta-Analysis","volume":"64","author":"Sheng","year":"2023","journal-title":"Acta Radiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00270-021-02896-0","article-title":"Utility of Real-Time CT\/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study","volume":"44","author":"Han","year":"2021","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2316097","DOI":"10.1080\/02656736.2024.2316097","article-title":"Three-Dimensional Ultrasound Fusion Imaging in Precise Needle Placement for Thermal Ablation of Hepatocellular Carcinoma","volume":"41","author":"Liu","year":"2024","journal-title":"Int. J. Hyperth."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jhep.2016.09.003","article-title":"Real-Time US-CT\/MR Fusion Imaging for Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma","volume":"66","author":"Ahn","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1007\/s00330-023-10412-w","article-title":"Current Use of Percutaneous Image-Guided Tumor Ablation for the Therapy of Liver Tumors: Lessons Learned from the Registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018\u20132022","volume":"34","author":"Zensen","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Minami, Y., Aoki, T., Hagiwara, S., and Kudo, M. (2023). Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15194763"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00330-023-10023-5","article-title":"3D Fusion Is Superior to 2D Point-to-Point Contrast-Enhanced US to Evaluate the Ablative Margin after RFA for Hepatocellular Carcinoma","volume":"34","author":"Long","year":"2023","journal-title":"Eur. Radiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/14737140.2023.2247564","article-title":"Ablative Margins in Percutaneous Thermal Ablation of Hepatic Tumors: A Systematic Review","volume":"23","author":"Verdonschot","year":"2023","journal-title":"Expert. Rev. Anticancer Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00270-025-04111-w","article-title":"CT-Guided Thermal Ablation of Liver Tumors Using Intraprocedural CT-CT Fusion for Applicator Position and Ablation Completeness Assessment: A Single-Center Comparative Analysis","volume":"48","author":"Verdonschot","year":"2025","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11912-020-00967-y","article-title":"What\u2019s New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update","volume":"22","author":"Arellano","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"14225","DOI":"10.1002\/cam4.6089","article-title":"Efficacy of Fusion Imaging for Immediate Post-ablation Assessment of Malignant Liver Neoplasms: A Systematic Review","volume":"12","author":"Rai","year":"2023","journal-title":"Cancer Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"20220086","DOI":"10.1259\/bjr.20220086","article-title":"Percutaneous Ablative Therapies for Hepatocellular Carcinoma in the Caudate Lobe of the Liver: Efficacy and Outcome","volume":"96","author":"Mukund","year":"2023","journal-title":"Br. J. Radiol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/19\/3251\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:05Z","timestamp":1760035805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/19\/3251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":160,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["cancers17193251"],"URL":"https:\/\/doi.org\/10.3390\/cancers17193251","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}